March 2014: Breaking the Habit

There is a single tie that binds large numbers of capital markets firms, irrespective of their location, the nature of their business, their assets under management, and their investment strategies: Many have become habitual users of Microsoft Excel, which, since it superseded Multiplan as the business-focused calculation engine of choice back in the late 1980s, has permeated every facet of the financial services industry. But as Anthony Malakian argues in his feature this month, it’s time to break this habit.
Snuffing out our individual vices is anything but trivial, but when compared to many capital markets firms and the extent to which they have become reliant on Microsoft’s wonder app, our personal tribulations pale into insignificant. After all, how does one even begin to contemplate a lobotomy-type procedure, where removing large parts of the firm’s brain is at best likely to affect the normal functioning of its entire body, or worse, kill it altogether? It’s a conundrum that many firms face as pressure from institutional investors and regulators demand industry best practices from a technology standpoint. For buy-side firms so reliant on the life-blood of hugely lucrative institutional mandates, the proposition is a stark one: adapt or die. Granted, software licenses and implementations are expensive, sometimes prohibitively so. But in this day and age of variable pricing structures and cloud-based software, there really isn’t any excuse for possessing sub-par technology, especially if you’re managing someone else’s money. If financial services firms cannot find an appropriate technology partner and the requisite applications to automate and systematize their processes, they simply aren’t looking hard enough.
Breaking habits involves pain and discomfort, but as the saying goes, long-term gain is worth short-term pain. From a buy-side perspective, institutional capital makes the world go round, and, if you’re an investment shop with institutional aspirations, you’ll need something more substantial than a performance record featuring a five-year winning streak. Trustees, despite how open-minded they might be, will not make allocations to a bunch of spreadsheet jockeys, irrespective of their performance. They just won’t. Period.
On a lighter note, US readers will be delighted to learn that they’re not alone in their Excel plight: According to the European Spreadsheet Risks Interest Group, the Securities and Exchange Commission (SEC) has its own Excel affliction. In a report published on the Group’s website on Nov. 16, 2011 under the “Horror Stories” tab, the SEC was named and shamed. “Many of the Agency’s financial reporting processes are still manual in nature and reliant on spreadsheets and databases to both initiate transactions and perform key control functions,” states the report. However, next time the SEC comes knocking, it’s probably not a good idea to cite this example of its technology frailties.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.
AI fails for many reasons but succeeds for few
Firms hoping to achieve ROI on their AI efforts must focus on data, partnerships, and scale—but a fundamental roadblock remains.
Waters Wavelength Ep. 330: AI hot takes
It’s Shen and Reb this week talking about AI and the landscape for fintech partnerships.